Details for New Drug Application (NDA): 209781
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 209781
Tradename: | LEVETIRACETAM |
Applicant: | Hainan Poly Pharm |
Ingredient: | levetiracetam |
Patents: | 0 |
Pharmacology for NDA: 209781
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 209781
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 209781 | ANDA | TAGI Pharma, Inc. | 51224-013 | 51224-013-10 | 10 VIAL, SINGLE-USE in 1 CARTON (51224-013-10) / 5 mL in 1 VIAL, SINGLE-USE |
LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 209781 | ANDA | TAGI Pharma, Inc. | 51224-013 | 51224-013-25 | 25 VIAL, SINGLE-USE in 1 CARTON (51224-013-25) / 5 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 500MG/5ML (100MG/ML) | ||||
Approval Date: | Mar 20, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription